3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
4
Leukemia, Myeloid, Acute
3
Lymphoma, Non-Hodgkin
2
Carcinoma, Basal Cell
2
Breast Diseases
2
Basal Cell Nevus Syndrome
2
Upper Tract Urothelial Carcinomas
1
Thrombocythemia, Essential
1
Solid Tumors
1
Serous Ovarian Cancer
1
Recurrence
1
Postmenopausal Women With ER+ HER2- Primary Breast Cancer
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Lymphedema
1
Leukemia
1
Immunoglobulin Light-chain Amyloidosis
1
Hypogonadism
1
Glioma
1
Gastric Adenocarcinoma
1
Fatigue Syndrome, Chronic
1
Eunuchism
1
Colorectal Neoplasms
1
Amyloidosis
1
Adenoma
1
Interventions
Manual Lymphatic Drainage
10
Exercise
10
Low-Level Light Therapy
6
Standard of Care
4
Physical Therapy Modalities
4
Exercise Therapy
4
Acupuncture Therapy
4
Resistance Training
3
Methods
3
Indocyanine Green
3
Compression Bandages
3
pycnogenols
2
Yoga
2
Technetium Tc 99m Sulfur Colloid
2
Radiotherapy
2
Pentoxifylline
2
Lipectomy
2
High-Energy Shock Waves
2
Early Intervention, Educational
2
Control Groups
2
Bupivacaine
2
Bevacizumab
2
specific substance maruyama
1
pirfenidone
1
pazopanib
1
carbohydrate-deficient transferrin
1
Wound Closure Techniques
1
Weights and Measures
1
Weight Reduction Programs
1
Vitamin E
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lymphedema
×
Drug Evaluation
×
Clear all
NCT01893879
2017-05-18
PCTTPL
Stanford University
Phase NA
Terminated
14 enrolled
5 charts